Subscribe to Vedolizumab-5060: Association Between Disease Activity and QoL, Fatigue, Mood and Sleep Disorders in Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease Treated with Vedolizumab - A Prospective, Observational Study Based on Patient Reported Outcomes (KUJAWIAK)